Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CASI Pharmaceuticals (DE:ENM)
STUTTGART:ENM
RESEARCH TOOLSreports
CASI Pharmaceuticals (ENM) Financial Statements
0 Followers
CASI Pharmaceuticals Financial Overview
| Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 15.32M | $ 10.21M | $ 8.57M | $ 9.06M | $ 9.16M |
| Gross Profit | $ 10.99M | $ 5.97M | $ 5.02M | $ 5.30M | $ 5.36M |
| EBIT | $ -16.54M | $ -5.01M | $ -7.75M | $ -7.29M | $ -11.44M |
| EBITDA | $ -15.65M | - | $ -7.41M | $ -6.86M | $ -11.02M |
| Net Income Common Stockholders | $ -19.54M | $ -5.20M | $ -7.68M | $ -8.60M | $ -5.60M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 49.88M | $ 35.55M | $ 24.57M | $ 37.48M | $ 48.57M |
| Total Assets | $ 96.23M | $ 127.91M | $ 118.86M | $ 129.56M | $ 138.30M |
| Total Debt | $ 0.00 | $ 3.00M | $ 2.90M | $ 1.88M | $ 2.17M |
| Net Debt | $ -49.88M | $ -32.55M | $ -21.67M | $ -35.60M | $ -46.41M |
| Total Liabilities | $ 29.30M | $ 127.86M | $ 29.25M | $ 54.58M | $ 53.80M |
| Stockholders Equity | $ 44.57M | $ 61.67M | $ 66.94M | $ 74.99M | $ 84.50M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.27M | $ -6.99M | $ -8.91M | $ -6.53M | $ -12.86M |
| Operating Cash Flow | $ -843.00K | - | $ -9.48M | $ -4.24M | $ -7.64M |
| Investing Cash Flow | $ 17.95M | - | $ -961.00K | $ -2.29M | $ -4.74M |
| Financing Cash Flow | $ -3.27M | - | $ 1.00M | $ -3.00M | $ -1.08M |
CASI Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.